A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
Clinical trial NCT05654623 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05654623
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2025-01-31
- Enrollment
- 624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.